Company / Goodwill
Pfizer Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$71.3B
FY2025
5-year range
$49.2B / $71.3B
FY2021-FY2025
Trend
+4.0%
vs FY2024
Sector context
#1 of 74
Health Care
What the data says
Among 74 Health Care companies, Pfizer is in the top 1% for goodwill. Goodwill has increased for 3 consecutive years, from $49.2B in FY2022 to $71.3B in FY2025.
Based on SEC 10-K filings.
$71.3B in FY2025 with a 5-year CAGR of +7.5%. Ranks 1st among 74 companies in Health Care.
Improved from $51.4B to $71.3B over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +13.1%
- 5-Year CAGR
- +7.5%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 74This company $71.3B Sector average $4.0B
▼
+1674.3% above sector average
Key checks
Key Insights
- Pfizer's goodwill has grown for 3 consecutive years.
- 5-year CAGR of +7.5%, indicating consistent growth.
- In FY2025, goodwill increased 4.0% year-over-year.
- Ranks #1 out of 74 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $71.3B | +4.0% |
| FY2024 | $68.5B | +33.4% |
| FY2023 | $51.4B | +4.4% |
| FY2022 | $49.2B | -0.7% |
| FY2021 | $49.6B | +0.0% |
| FY2020 | $49.6B | +2.9% |
| FY2019 | $48.2B | -13.9% |
| FY2018 | $56.0B | +2.8% |
| FY2017 | $54.4B | +12.9% |
| FY2016 | $48.2B | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026